Arcutis Biotherapeutics (AQRT) PT Raised to $35 at Guggenheim
Tweet
Share
E-mail
Guggenheim analyst Seamus Fernandez raised the price target on Arcutis Biotherapeutics (: AQRT) to $35.00 (from $34.00) while maintaining a Buy rating.
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Zedcor Inc (ZDC:CN) PT Raised to Cdn$7.75 at Desjardins
- Calian Group Ltd (CGY:CN) (CLNFF) PT Raised to Cdn$109 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
